A system and method for locating magnetic material. In one embodiment the system includes a magnetic probe; a power module in electrical communication with the magnetic probe to supply current to the magnetic probe; a sense module in electrical communication with the magnetic probe to receive signals from the magnetic probe; and a processing module in electrical communication with the power module and the sense module. The processing module generates a waveform that controls the supply of current from the power module and receives a signal from the sense module that indicates the presence of magnetic material. The magnetic probe is constructed from a material having a coefficient of thermal expansion of substantially 10−6/° C. or less and a Young's modulus of substantially 50 GPa or greater. In one embodiment magnetic nanoparticles collect in the lymph nodes. In one embodiment the particles have a mean hydrodynamic diameter of between 5-200 nm.

Patent
   9427186
Priority
Dec 04 2009
Filed
Dec 06 2010
Issued
Aug 30 2016
Expiry
Jul 21 2031
Extension
594 days
Assg.orig
Entity
Large
3
182
currently ok
1. A system for locating a magnetic marker in a patient comprising:
a magnetic probe comprising;
a drive coil for producing an alternating magnetic field; and
a sense coil for detecting a magnetic field as generated by the magnetic marker in response to the alternating magnetic field produced by the drive coil,
wherein the drive coil and sense coil having different radii, and being spaced axially from each other; and
wherein the axial spacing between the drive coil and the sense coils is such that as the radius of the larger coil varies from an initial radius the change in the mutual inductance between the sense coil and the drive coil caused by the change in radius of the larger coil is zero,
a power module in electrical communication with the magnetic probe to supply current to the magnetic probe;
an amplifier in electrical communication with the magnetic probe to receive signals from the magnetic probe;
a processing module in electrical communication with the power module and the amplifier; and
a plurality of magnetic nanoparticles,
wherein the processing module generates a waveform that controls the supply of current from the power module to the magnetic probe;
wherein the processing module receives a signal from the amplifier that indicates the proximity to the injectable magnetic nanoparticles; and
wherein the magnetic nanoparticles have a mean diameter size of greater than 200 nm thereby not to migrate but remain positioned at the site of introduction.
2. The system of claim 1 wherein the injectable magnetic nanoparticles have a mean diameter size of greater than 1000 nm.
3. The system of claim 1 further comprising a second drive coil having a different radius that the sense coil.
4. The system of claim 3 wherein said drive coils form a first order gradiometer.
5. The system of claim 1 further comprising a second sense coil having a different radius that the drive coil.
6. The system of claim 5 wherein said sense coils form a first order gradiometer.

This application is a continuation-in-part of Ser. No. 12/631,370 filed on Dec. 4, 2009, the entire contents of which are incorporated by reference herein.

This invention relates to the field of medical diagnostic devices and more specifically to a device to detect tissues of interest during a surgical procedure.

Approximately 1.25 million new cases of breast cancer are diagnosed each year. In a majority of these cases, there is an urgent need for surgery to remove the tumor and to excise the sentinel lymph nodes and inspect them histologically to determine whether the cancer has spread to other sites in the body. The sentinel lymph nodes are the first nodes to receive lymphatic drainage from the tumor. They are called this because they reliably alert the clinician to any cancer spread. A sentinel lymph node biopsy is a standard of care in breast cancer operations today.

Locating sentinel nodes during surgery is difficult. One method for locating the sentinel node is to inject a dark blue dye into the lymphatic system in the breast. The dye then disperses throughout the breast lymphatic system and the surgeon removes any colored nodes. This method is recognized as being error-prone.

An improved method involves injecting a radioactive dye into the lymph nodes. In a similar manner, the dye drains through the lymphatic system and the surgeon then uses a radiation detector to help locate the sentinel nodes. However, the use of radioisotopes presents a significant, and an expensive, logistical burden, because of the need to allocate the time and resources of a nuclear medicine radiologist in addition to the surgeon for what is otherwise a routine operation. Further many patients are reluctant to receive a radioactive injection. These factors become a significant barrier to the widespread adoption of the use of radioisotopes to locate the sentinel nodes.

In addition the ability to mark or tattoo a region is important to permit a surgeon to locate areas of interest. Most tattooing takes place on the surface of the skin or through the embedding of macro-objects such as staples in the tissue of interest. Unfortunately such surface tattooing only shows the surgeon the region of the surface below which the tissue of significance is located. It does not demark in the 3-D the location of the tissue. A way is needed to delineate, in 3-D, regions of interest for the surgeon.

Finally, metallic fragments dispersed through tissue are a frequent occurrence in combat and industrial accident related injuries. Finding these fragments are problematic for operating room surgeons attempting to repair tissue damage.

The present invention solves these issues.

The present invention radically alters the sentinel lymph node protocol through the use of a detection system based on magnetism rather than radiation. The present system combines the magnetic properties of a magnetic nanoparticle suspension with a detector that is significantly more sensitive than other methods that can be used in the environment of an operating theater. In one embodiment the nanoparticles suspension is an FDA approved MRI contrast agent. Although in one embodiment the present invention is directed to locating sentinel lymph nodes, it can be used to detect other magnetic and conductive materials both within a body and in other environments.

In one aspect, the invention relates to a system for locating magnetic material. In one embodiment the invention relates to a system for locating, in a patient, a sentinel node having injectable magnetic nanoparticles. In one embodiment the system comprises a magnetic probe; a power module in electrical communication with the magnetic probe to supply current to the magnetic probe; a sense module in electrical communication with the magnetic probe to receive signals from the magnetic probe; a computer or processing module in electrical communication with the power module and the sense module; and a plurality of injectable magnetic nanoparticles. In another embodiment the computer or processing module generates a waveform that controls the supply of current from the power module to the magnetic probe and receives a signal from the sense module that indicates the proximity to the injectable magnetic nanoparticles. In another embodiment the magnetic probe is constructed from a material having a coefficient of thermal expansion less than or equal to 10−6/° C. and a Young's modulus of substantially 50 GPa or more. In yet another embodiment the injectable magnetic nanoparticles have a mean hydrodynamic diameter size of between 5 and 200 nm and preferably between 10 and 50 nm.

In another aspect, the invention relates to a system for locating a magnetic marker in a patient. In one embodiment the system includes a magnetic probe; a power module in electrical communication with the magnetic probe to supply current to the magnetic probe; a sense module in electrical communication with the magnetic probe to receive signals from the magnetic probe; a computer or processing module in electrical communication with the power module and the sense module; and a plurality of injectable magnetic nanoparticles. In another embodiment the computer or processing module generates a waveform that controls the supply of current from the power module to the magnetic probe and receives a signal from the sense module that indicates the proximity to the injectable magnetic nanoparticles. In yet another embodiment the magnetic probe is constructed from a material having a coefficient of thermal expansion less than or equal to 10−6/° C. and a Young's modulus of substantially 50 GPa or more. In still yet another embodiment the injectable magnetic nanoparticles have a mean hydrodynamic diameter size of greater than 200 nm and preferably greater than 1000 nm.

In yet another aspect the invention relates to a handheld system for locating, in a patient, a sentinel node having magnetic material. In one embodiment the system includes a housing including a magnetic probe capable of detecting the magnetic material; a power module in electrical communication with the magnetic probe to supply current to the magnetic probe; a sense module in electrical communication with the magnetic probe to receive signals from the magnetic probe; a display module; and a computer or processing module in electrical communication with the power module, the display module and the sense module. In another embodiment the computer or processing module generates a waveform that controls the supply of current from the power module to the magnetic probe; and receives a signal from the sense module that indicates the proximity to the magnetic material. In yet another embodiment the display module provides an indication of the presence of magnetic material. In still yet another embodiment the magnetic probe is constructed from a material having a coefficient of thermal expansion less than or equal to 10−6/° C. and a Young's modulus of substantially 50 GPa or more. In one embodiment the indication of magnetic material is audible. In another embodiment the indication of magnetic material is tactile vibrations. In another embodiment the magnetic particles are magnetic nanoparticles having a mean hydrodynamic diameter of 5-200 nm and preferably between 10-50 nm.

In still yet another aspect the invention relates to a handheld probe for locating, in a patient, a sentinel node having magnetic material. In one embodiment the handheld probe includes a housing including a magnetic probe capable of detecting the magnetic material; a power module in electrical communication with the magnetic probe to supply current to the magnetic probe; a sense module in electrical communication with the magnetic probe to receive signals from the magnetic probe; a transmitter module including an antenna; and a or processing module in electrical communication with the power module, the transmitter module and the sense module. In another embodiment the computer or processing module generates a waveform that controls the supply of current from the power module to the magnetic probe and receives a signal from the sense module that indicates the proximity to the magnetic material. In yet another embodiment the computer or processing module instructs the transmitter module to transmit a signal indicating the presence of magnetic material in response to the signal from the sense module. In still yet another embodiment the magnetic probe is constructed from a material having a coefficient of thermal expansion less than or equal to 10−6/° C. and a Young's modulus of substantially 50 GPa or more.

In another aspect the invention relates to a system for locating, in a patient, a sentinel node having magnetic material. In one embodiment the system includes a housing including a magnetic probe capable of detecting the magnetic material; a power module in electrical communication with the magnetic probe to supply current to the magnetic probe; a sense module in electrical communication with the magnetic probe to receive signals from the magnetic probe; a transmitter module comprising an antenna; and a probe computer or processing module in electrical communication with the power module, the transmitter module and the sense module. In one embodiment the system includes a host computer having a receiver for receiving a transmitted signal from the transmitter module. In another embodiment the probe computer or processing module generates a waveform that controls the supply of current from the power module to the magnetic probe and receives a signal from the sense module that indicates the proximity to the magnetic material. In yet another embodiment the probe computer or processing module instructs the transmitter module to transmit a signal indicating the presence of magnetic material in response to the signal from the sense module. In still yet another embodiment the magnetic probe is constructed from a material having a coefficient of thermal expansion less than or equal to 10−6/° C. and a Young's modulus of substantially 50 GPa or more. In yet another embodiment the host computer generates an indication of the presence of magnetic material in response to the received signal transmitted from the transmitter module. In still yet another embodiment the system also includes a plurality of magnetic nanoparticles each magnetic nanoparticle having a mean hydrodynamic diameter of 5-200 nm and preferably 10-50 nm.

In another aspect the invention relates to a system for locating, in a patient conductive material. In one embodiment the system comprise a probe; a power module in electrical communication with the probe to supply current to the probe; a sense module in electrical communication with the probe to receive signals from the probe; and a computer or processing module in electrical communication with the power module and the sense module. In another embodiment the computer or processing module generates a waveform that controls the supply of current from the power module to the probe and receives a signal from the sense module that indicates the proximity to the conductive material. The probe is constructed from a material having a coefficient of thermal expansion less than or equal to 10−6/° C. and a Young's modulus of substantially 50 GPa or more. In one embodiment the signal from the probe is in phase with the waveform that controls the supply of current to the magnetic probe.

In another aspect the invention relates to a system for locating, in a patient a magnetic material. The system includes a probe; a power module in electrical communication with the probe to supply current to the probe; a sense module in electrical communication with the probe to receive signals from the probe; and a computer or processing module in electrical communication with the power module and the sense module. In one embodiment the or processing module generates a waveform that controls the supply of current from the power module to the probe and the computer or processing module receives a signal from the sense module that indicates the proximity to the conductive material. In another embodiment the probe is constructed from a material having a coefficient of thermal expansion less than or equal to 10−6/° C. and a Young's modulus of substantially 50 GPa or more. In yet another embodiment the phase of the signal from the probe is orthogonal to the phase of the waveform that controls the supply of current to the probe.

In still another aspect the invention relates to a system for locating, in a patient, a magnetic or conductive material. In one embodiment the system includes a probe; a power module in electrical communication with the probe to supply current to the probe; a sense module in electrical communication with the probe to receive signals from the probe; and a computer or processing module in electrical communication with the power module and the sense module. In one embodiment the computer or processing module generates a waveform that controls the supply of current from the power module to the probe and the computer or processing module receives a signal from the sense module that indicates the proximity to the magnetic or conductive material. In another embodiment the probe is constructed from a material having a coefficient of thermal expansion less than or equal to 10−6/° C. and a Young's modulus of substantially 50 GPa or more. In yet another embodiment the magnitude of signal from the probe is measured irrespective of the signal's phase relative to the phase with the waveform that controls the supply of current to the probe.

In another aspect the invention relates to a method for 3D-tattooing. The method includes the steps of providing a plurality of injectable magnetic or conductive particles; and injecting the magnetic or conductive particles into the regions of interest in a tissue.

The objects and features of the invention can be better understood with reference to the drawings described below. The drawings are not necessarily drawn to scale; emphasis is instead being placed on illustrating the principles of the invention. In the drawings, numerals are used to indicate specific parts throughout the various views. The drawings associated with the disclosure are addressed on an individual basis within the disclosure as they are introduced.

FIG. 1 is a block diagram of an embodiment of a system constructed in accordance with the invention;

FIG. 2 is a schematic diagram of the probe and electronic components of the embodiment of the system of the system shown in FIG. 1;

FIG. 2A is a schematic diagram of the probe and electronic components of another embodiment of the system of the system shown in FIG. 1;

FIG. 3 is a flow diagram of an embodiment the method of determining the sentinel nodes utilizing the invention;

FIG. 4 is a drawing of the probe of the system being used to locate a sentinel node;

FIG. 5 is a block diagram of another embodiment of the system constructed for wireless use; and

FIG. 6 is a block diagram of another embodiment of the system constructed for use without a remote host computer.

The following description refers to the accompanying drawings that illustrate certain embodiments of the invention. Other embodiments are possible and modifications may be made to the embodiments without departing from the spirit and scope of the invention. Therefore, the following detailed description is not meant to limit the invention. Rather, the scope of the invention is defined by the appended claims.

Referring to FIG. 1, in brief overview, a system 10 constructed in accordance with the teachings of the invention includes a computer 14 having a processor, RAM memory, long term data storage, input/output devices and display; an electronic module 16 containing the power and sensor electronics for the probe and the probe itself 100. As referred to herein the words compute, processor and processing module are used interchangeably to denote any form of processing device including digital and analog implementations. In one embodiment the input/output devices include a digital to analog converter and an analog to digital converter.

To maintain the stability of the system, it is necessary in part to provide thermal stability in the probe. This is done with a combination of a material having a combination of low thermal expansion and a high resistance to deformation with a careful positioning of the coils of the probe. Referring to FIG. 2, an embodiment of the electronics and probe components of the system of the invention includes the probe 100, a drive circuit 104 and a sense circuit 108. The probe 100 is generally a cylindrically shaped device sized to fit the hand of a user. In one embodiment the cylinder is about 75 mm long and 20 mm in diameter. In one embodiment the cylinder is made of Zerodur®, (Schott A G, Mainz, Germany) which is an inorganic, non-porous glass ceramic that has a non-directional, isotropic structure. During formation, this glass ceramic is subjected to thermal cycling which converts about 75% of the vitreous material into crystalline quartz. The resulting glass and crystal phases within the material balance such that the thermal expansion coefficient of one form of Zerodur® is of the order 0.02×10−6/° C. The substantially zero coefficient of expansion maintains the mechanical stability of the probe 100 over a wide temperature range. In addition the glass ceramic material is very stiff, having a Young's modulus of 90 GPa. Other materials with coefficients of thermal expansion and Young's modulus similar to this material may also be used.

In one embodiment two grooves 112 and 116 are circumferentially formed near the first end of the cylinder body and two substantially identically sized coils of wire 120, 124 are wound in the grooves. A third groove 128 is also formed in the cylinder substantially midway between and coaxial with the first 112 and second 116 grooves and a third coil 132 wound in that groove 128. In this embodiment the depth of the third groove 128 is such that the outer surface of the third coil 132 is located at the same depth as the bottom of the first 112 and second 116 grooves and the groove 128 is wider than the other two grooves. In one embodiment the first 120 and second 124 coils are about 2 mm wide; have an inner radius of about 8 mm; and have about 48 turns of wire. The third coil 132 is about 3 mm wide; has an inner radius of about 5 mm and contains about 72 turns of wire.

The size of the coils and their placement relative to each other is selected so that as the coils change shape because of heating, their inductive change is minimized. Unfortunately there are presently no available electrical conductors with zero coefficient of thermal expansion. Tungsten wire offers an improvement over copper wire, reducing the coefficient by a factor of four, but it also suffers from four times the resistivity. For the drive coils 120, 124 the higher resistivity causes increased self-heating, for sense coils 132 the increased resistivity increases the noise, so in the embodiments shown tungsten was not used.

The problem of differential radial expansion of the coils cannot be addressed through material selection, but it can be handled by careful calculation of coil geometry. Consider the coupling (mutual inductance) between a pair of coaxial coils, one of which has a larger radius than the other. If the coils are close together, then the coupling is reduced as the larger coil expands. If the coils are far apart, the coupling increases as the larger coil expands. Thus it is evident that there is a separation at which the coupling is unaffected by small expansions of the larger coil.

With real coils of non-zero radius, length and thickness, the mutual inductance can be calculated numerically as an integral of order 6 over the two coil volumes. Assuming the radii are selected first, the required separation may be determined iteratively. The mutual inductance between two filamentary circuits i and j is given by the Neumann formula:

M ij = μ 4 π C i C j s i · s j R ij
where Rij is the distance between elements dsi and dsj on circuits Ci and Cj and μ is the magnetic permeability of the material between the filamentary circuits, which for glass ceramics is typically very close to μ0, the permeability of free space.

For volume-filling coaxial cylindrical coils, this equation becomes (in cylindrical polar coordinates (r, θ, z):

M ij = μ 4 π N i N j r j 0 r j 1 r i 0 r i 1 z j 0 z j 1 z i 0 z i 1 - π π - π π cos ( θ i - θ j ) R ij r i θ i r j θ j z i z i 1 - z i 0 z j z j 1 - z j 0 r i r i 1 - r i 0 r j r j 1 - r j 0 where R ij 2 = r i 2 + r j 2 - 2 r i r j cos ( θ i - θ j ) + ( z i - z j ) 2
and where Ni, Nj are the number of turns on each coil. This equation assumes a uniform current distribution over the coil cross-section, which is valid for low frequency and small wire size so that the skin effect can be neglected.

Given axial symmetry, one integral reduces to the circumference of a circle, leaving the following formula to be integrated numerically:

M ij = μ N i N j r j 0 r j 1 r i 0 r i 1 z j 0 z j 1 z i 0 z i 1 r i r j 0 π cos ( θ j ) θ j r i 2 + r j 2 - 2 r i r j cos ( θ j ) + ( z i - z j ) 2 z i z i 1 - z i 0 z j z j 1 - z j 0 r i r i 1 - r i 0 r j r j 1 - r j 0

It should be understood that the coil coupling is only insensitive to variation in the size of the larger coil, not to variation in the size of the smaller coil. For this technique to be effective, it is therefore necessary that the smaller coil is the central coil within a first order gradiometer made from two equal larger coils. Any change in the radius of the centre coil is balanced by an equal change in coupling to the coils on either side of it. A change in radius of either larger coil is compensated by its correct positioning.

A fourth groove 136 is also formed in the cylinder to reduce the thermal conductivity of the cylinder in use and reduce the amount of any heat generated by the coils 120, 124 from flowing along the cylinder causing a thermal asymmetry and thereby making the local environment of the two coils 120, 124 different. Two longitudinal grooves (not shown) are also formed in the surface along the length of the cylinder to provide paths for the wire connections to the various coils.

An optional fifth groove 140 may be formed near the end of the cylinder away from the first groove 112, and an optional fourth coil 144 formed in the groove 140. In one embodiment, the fourth coil 144 is about 2 mm wide; has an inner radius of 8 mm and has about 32 turns of wire. Although the fourth coil 144 is larger than the third coil 132, their area-turns are substantially matched.

In one embodiment the first 120 and second 124 coils are counter wound and connected in series such that when energized by a current, the magnetic fields they produce are substantially cancelled at the center of the third coil 132. For the purposes of this discussion, unless otherwise stated, the first 120 and second 124 coils are referred to as the drive coils and the third coil 132 as the sense coil. Also the fourth optional coil 144 will also be referred to as an optional sense coil.

Power is supplied to the drive coils 120, 124 by the drive circuit 104. The drive circuit includes a voltage to current amplifier 148 and an inverting power amplifier 152. In one embodiment the computer (not shown) generates a sine wave of appropriate amplitude and frequency and the digital to analog converter within the computer generates an analog voltage from this generated sine wave. In one embodiment the frequency of the sine wave is 10 kHz. The voltage to current amplifier 148 converts that voltage to a current used to power the drive coils 120, 124 through one series connected conductor 156. In one embodiment the current is 100 mA. The current return conductor 160 is connected to the output terminal of the inverting power amplifier 152 whose input terminal is also connected to the output of the voltage to current amplifier 148. This configuration produces a balanced +V on one side of the drive coils 120, 124 and −V on the other side of the drive coils 120, 124.

The sense circuit 108 includes a first stage amplifier 164, a summing junction 168, a second stage amplifier 172, and an offset correction circuit 176. A signal received from the sense coil 132 is the input signal to the first stage sense amplifier 164. In one embodiment this amplifier has a gain of 250. The output of the first stage gain amplifier 164 is one input to the summing junction 168. The output of the summing junction 168 is the input to the second stage amplifier 172. In one embodiment the second stage amplifier has a gain of 400. The output of the second stage amplifier 172 is the input to the offset correction circuit 176 and the input to the analog to digital converter (not shown) connected to the computer (not shown).

The offset correction circuit 176 integrates the output of the second stage amplifier 172 and its output is a second input to the summing junction 168. The output of the offset correction circuit 176 provides a feedback signal in response to a positive offset to generate a negative ramp signal.

The third input to the summing junction 168 is a software controlled balance signal 180. This signal, which is generated by a second digital to analog converter (not shown) of the computer, is the signal which compensates for any unbalance in the sense coils 120, 124. To perform this compensation function the probe 100 is held pointing to open space. The computer (not shown) generates a compensating balance signal 180 and measures the change of amplitude and phase of the output signal 184 through the A/D converter. The computer then calculates the vector (amplitude and phase) for the balance signal 180 necessary to null the output signal 184.

Thus the balancing process determines the balance phasor required to obtain a near-zero output from the system. Normally balancing starts with the existing value. When starting without a prior value it may be necessary to use a lower drive current initially to avoid saturating the input, and then repeat the balancing at the required drive current.

The system measures the response S0 at the original balance setting B0, then adjusts the balance phasor by a small amount to B1 and measures the new response S1. The coupling from the balance output to the detected input is defined by:

X = S 1 - S 0 B 1 - B 0
which is the rate of change of the response to balance and therefore the new balance is reached when:

B 2 = B 0 - S 0 X

Alternatively the computer can generate a balance signal 180, measure the output signal 184 and modify the balance signal 180 iteratively until the output signal 184 is nulled.

To reduce the noise in the system, the optional sense coil 144 is utilized. This coil 144 is positioned away from the drive coils 120, 124 and generally detects the magnetic flux in the operating room and not the magnetic flux from the drive coils 120. This optional coil 144 can be connected in series with the sense coil 132 such that any ambient magnetic field will produce a current in the optional sense coil 144 that is in opposition to the current that is produced by the ambient magnetic field on the sense coil 132, thereby canceling the effects of the ambient magnetic field on the probe 100. It should be noted that when coils are configured to cancel the effects of other coils, the coils canceling each other may be counter wound, or connected in series with their input and output leads reversed.

Further, referring to FIG. 2A, the functions of the drive coils 120, 124 and the sense coil 132 can be reversed. If this is done this forms an embodiment in which there are two sense coils 120′, 124′ connected in opposition and a drive coil 132′ positioned between them. The sense coils 120′, 124′ are constructed such that the field from the drive coil 132′ produces a current in each of the sense coils 120′, 124′ that is equal and opposite to the current produced in the other sense coil 124′, 120′. The optional sense coil 144 is not needed in this configuration.

Referring again to FIG. 2, to reduce the noise in the system, the power to the coils 120, 124 and the signals from the sense coil 132 to the sense electronics 108 are each conducted by a twisted quad microphone cable 162 for improved magnetic field rejection. The twisted pair for the sense coil 132 is not shown for clarity. Further the two twisted quad cables are both embedded in a longitudinally flexible yet laterally stiff sheath which prevents the conductors from moving relative to one another.

The output signal 184 from the sense circuit 108 is digitized by the computer's 14 analog to digital converter to provide an output time series. This time series is correlated to the output series generated by the computer 14.

In particular, detection of the magnetic particles involves correlating the sampled input waveform with two sinusoidal reference waveforms, one in phase with the drive and one in quadrature. The result is a phasor; a complex number giving the amplitude and phase of the probe response:

S = 2 N C i V i N + i 2 N S i V i N
where Vi is the sampled input voltage and Ci and Si are sampled cosine and sine waves respectively, and the input is processed in sections of N samples.

It is possible to use the amplitude |S| as the system indication, in which case both magnetic and conductive materials are detected, or to use the dot product with a discrimination phasor to detect only the magnetic component. This works because the eddy current induced in a conductive material is in quadrature with the applied field, while the magnetization of a magnetic material at low frequency is in phase with the applied field. Thus the system can be used not only for detecting magnetic materials but also conductive materials alone or in conjunction with magnetizable material. This function is extremely important for finding metal shrapnel in the body quickly; because much shrapnel is non-magnetic. This function is also useful in detecting intentionally implanted conductive materials such as staples and screws in tissue.

In more detail, the detected signal from a conductive non-magnetizable object is in quadrature with the detected signal from a magnetizable non-conductive object. In the conductive case, the sense coil voltage is actually in anti-phase with the drive coil current, and in the magnetizable case the sense coil voltage is in quadrature with the drive coil current. In the conductive case, the drive coil current produces a proportional magnetic flux (0° with respect to the drive coil), the rate of change of which induces a voltage (90° with respect to the drive coil) in the metal, which in turn drives a current (90° with respect to the drive coil), which produces a magnetic flux in the sense coil (90° with respect to the drive coil), the rate of change of which induces a voltage in the sense coil (180° with respect to the drive coil).

In use, as the probe 100 is positioned closer to a node with magnetic or conductive particles, the results are displayed, in one embodiment, by the computer as an audible sound of increasing frequency and a graphics display of counts proportional to the detected field.

Referring to FIG. 3, during a surgical operation, a surgeon injects (Step 100) the breast with a suspension of magnetic nanoparticles near a tumor 190 (FIG. 4). In one embodiment the nanoparticles are those used as an MRI contrast agent. Feridex® (Bayer HealthCare Pharmaceuticals, Montville, N.J.) or Endorem™ (Guerbet, Paris, France) are ferum oxides used generally as an MRI contrast agent which are suitable for the magnetic detection purpose. When used for searching for sentinel nodes, the magnetic nanoparticles, although having a distribution of hydrodynamic diameters, are selected such that the majority typically have a mean hydrodynamic diameter size of 5-200 nm and more preferably 10-50 nm.

After a period of time the suspension drains into the axillary lymphatic system on the same side as the breast. The surgeon then places (Step 104, FIG. 3) the probe 100 on the surface of the skin, attempting to localize a lymph node 200 (FIG. 4) by determining if magnetic particles are detected (Step 108). If not (Step 112) the surgeon continues to search for a node by placing the probe 100 in another location on the surface of the skin and the process repeats. If a magnetic region is detected, the surgeon then makes an incision (Step 114) and attempts to localize the node with magnetic particles using the probe (Step 115). If the node has accumulated the magnetic nanoparticles, it is deemed (Step 116) a sentinel node. The node is then excised (Step 120). The surgeon then looks for additional nodes (Step 121) which may also be sentinel nodes and when complete sends the excised nodes for histological examination for evidence of cancer (Step 124).

In addition, by using nanoparticles greater than 200 nm and more preferably greater than 1000 nm in diameter, the particles tend to stay where injected. This is useful in marking a site for surgery. This type of marking which herein is referred to as 3D tattooing permits the surgeon to locate various points in a region prior to the surgical operation and then be able to return and find those points later during surgery by using the probe.

For example this technique can be used to mark the edges of a tumor bed prior to adjuvant therapy. As the tumor shrinks during the chemotherapy, the margins are still locatable so that the tissue can be removed even if the tumor is no longer palpable. Similarly the 3D tattoo can be used to locate the point of a biopsy so that if the biopsy discloses a cancerous tumor, the exact point of the biopsy can be determined. Finally, this technique is suitable for use when no palpable tumors are felt, such as in DCIS (Ductal Carcinoma in Situ). For this 3-D tattooing use, a clinician injects small amounts of magnetic nanoparticles having a size greater than 200 nm and more preferably greater than 1000 nm at one or more points in a region of interest to the surgeon. During surgery the surgeon can detect these particles using the probe described.

Referring to FIG. 5, the system of the invention may be used to study the long term properties of magnetic materials either in a biological context or otherwise. In one embodiment the probe 100′ of the invention is reduced in size and rather than being held by a user is placed in a small capsule 250 that is attached to the object of interest 254 by an adhesive 258. The capsule 250 also houses a power supply battery 262, the probe electronics 16′, a microprocessor and transmitter 266 and an antenna 270. The output of the probe electronics 16′ is digitized by the microprocessor 266 and the data transmitted using the antenna 270 to a receiving host computer system (not shown). The receiving host computer in one embodiment signals the presence of the magnetic material. This embodiment for example is useful in tracking the behavior of magnetic particles without requiring that the patient or object be tethered to the computer system 14 by wires.

Referring to FIG. 6, the system of the invention may be used to study the long term properties of magnetic materials or be used as a probe in surgery without requiring a receiving computer system. In one embodiment the probe 100′ of the invention is placed in a housing 251 suitable for holding in the hand. The housing 251 also houses a power supply battery 262, the probe electronics 16′, a microprocessor 267 and a display unit 271. The output of the probe electronics 16′ is digitized by the microprocessor 267 and processed and the results displayed by the display unit 271. This display unit in various embodiments includes a visual display, an audible display (that, for example, becomes louder), or a vibratory tactile display (that, for example, vibrates more) as the probe approaches the magnetic or conductive material.

It is to be understood that the figures and descriptions of the invention have been simplified to illustrate elements that are relevant for a clear understanding of the invention, while eliminating, for purposes of clarity, other elements. Those of ordinary skill in the art will recognize, however, that these and other elements may be desirable. However, because such elements are well known in the art, and because they do not facilitate a better understanding of the invention, a discussion of such elements is not provided herein. It should be appreciated that the figures are presented for illustrative purposes and not as construction drawings. Omitted details and modifications or alternative embodiments are within the purview of persons of ordinary skill in the art.

It can be appreciated that, in certain aspects of the invention, a single component may be replaced by multiple components, and multiple components may be replaced by a single component, to provide an element or structure or to perform a given function or functions. Except where such substitution would not be operative to practice certain embodiments of the invention, such substitution is considered within the scope of the invention.

The examples presented herein are intended to illustrate potential and specific implementations of the invention. It can be appreciated that the examples are intended primarily for purposes of illustration of the invention for those skilled in the art. There may be variations to these diagrams or the operations described herein without departing from the spirit of the invention. For instance, in certain cases, method steps or operations may be performed or executed in differing order, or operations may be added, deleted or modified.

Furthermore, whereas particular embodiments of the invention have been described herein for the purpose of illustrating the invention and not for the purpose of limiting the same, it will be appreciated by those of ordinary skill in the art that numerous variations of the details, materials and arrangement of elements, steps, structures, and/or parts may be made within the principle and scope of the invention without departing from the invention as described in the claims.

Variations, modification, and other implementations of what is described herein will occur to those of ordinary skill in the art without departing from the spirit and scope of the invention as claimed. Accordingly, the invention is to be defined not by the preceding illustrative description, but instead by the spirit and scope of the following claims.

Hattersley, Simon Richard, Pankhurst, Quentin Andrew

Patent Priority Assignee Title
10898105, Jun 06 2016 Temple University--Of The Commonwealth System of Higher Education Magnetometer surgical device
11464420, Jun 06 2016 Temple University-Of The Commonwealth System of Higher Education Magnetometer surgical device
11998306, Aug 24 2014 Health Beacons, Inc. Probe for determining magnetic marker locations
Patent Priority Assignee Title
2614164,
3445928,
3449662,
4324255, Mar 07 1980 Method and apparatus for measuring magnetic fields and electrical currents in biological and other systems
4654880, Dec 09 1983 Cochlear Corporation Signal transmission system
4825162, Dec 07 1987 General Electric Company Nuclear magnetic resonance (NMR) imaging with multiple surface coils
4983912, Mar 29 1989 Siemens Aktiengesellschaft Method for calibrating SQUID gradiometers of an arbitrary order
5005001, Apr 05 1990 Pitney Bowes Inc. Field generation and reception system for electronic article surveillance
5184070, Jan 29 1991 INSTITUT DR FRIEDRICH FORSTER PRUFERATEBAU GMBH & CO KG Eddy-current defect test instrument with multiple test probes and one distance probe
5261403, Mar 30 1987 Hitachi Medical Corporation Magnetic resonance imaging apparatus
5293119, Feb 20 1992 SQM Technology, Inc. Electromagnetic microscope for evaluation of electrically conductive and magnetic materials
5363845, Aug 13 1993 Medical Advances, Inc. Breast coil for magnetic resonance imaging
5402094, Aug 15 1994 MRI mammography magnet
5414356, Sep 21 1987 HITACHI, LTD A CORPORATION OF JAPAN Fluxmeter including squid and pickup coil with flux guiding core and method for sensing degree of deterioration of an object
5416413, Aug 13 1992 U. S. Philips Corporation Magnetic resonance examination apparatus comprising a coil system for MR mammography
5437280, Sep 20 1993 Magnetic resonance breast localizer
5512821, Jun 04 1991 NKK Corporation Method and apparatus for magnetically detecting defects in an object with compensation for magnetic field shift by means of a compensating coil
5534778, Aug 24 1993 U S PHILIPS CORPORATION Magnetic resonance apparatus
5537037, Mar 16 1993 Hitachi, Ltd. Apparatus with cancel coil assembly for cancelling a field parallel to an axial direction to the plural coils and to a squid pick up coil
5657756, Jun 07 1995 VSM MEDTECH SYSTEMS INC Method and systems for obtaining higher order gradiometer measurements with lower order gradiometers
5666052, Mar 06 1992 Daikin Industries, Ltd. Magnetic sensor having a superconducting quantum interference device and a pickup coil wound on a tubular resinous bobbin with embedded high thermal conductivity material
5844140, Aug 27 1996 P D COOP, INC Ultrasound beam alignment servo
5942209, Mar 11 1996 Genzyme Corporation Method of local radiotherapy by polymerizing a material in vivo to form a hydrogel
5997473, Sep 06 1996 Olympus Optical Co., Ltd.; OLYMPUS OPTICAL CO , LTD Method of locating a coil which consists of determining the space occupied by a source coil generating a magnetic field
6076008, Apr 26 1993 St. Louis University System for indicating the position of a surgical probe within a head on an image of the head
6082366, Sep 05 1995 ANDRAE, WILFRIED; BELLEMAN, MATTHIAS ERICH; DANAN, HENRI Method and arrangement for determining the position of a marker in an organic cavity
6173715, Mar 01 1999 Lucent Medical Systems, Inc. Magnetic anatomical marker and method of use
6205352, Nov 19 1997 CAROLL, ROBERT G Sentinel node identification using non-isotope means
6230038, Feb 01 1999 International Business Machines Corporation; IBM Corporation Imaging of internal structures of living bodies by sensing implanted magnetic devices
6270464, Jun 22 1998 DEVICOR MEDICAL PRODUCTS, INC Biopsy localization method and device
6304075, Dec 27 1996 Bic-Niesse GmbH --Business and Innovation Centre in der Euroregion Neisse Magnetic resonance sensor
6347241, Feb 02 1999 SenoRx, Inc. Ultrasonic and x-ray detectable biopsy site marker and apparatus for applying it
6356782, Dec 24 1998 DEVICOR MEDICAL PRODUCTS, INC Subcutaneous cavity marking device and method
6371904, Dec 24 1998 DEVICOR MEDICAL PRODUCTS, INC Subcutaneous cavity marking device and method
6394965, Aug 15 2000 CARBON MEDICAL TECHNOLOGIES, INC Tissue marking using biocompatible microparticles
6406420, Jan 02 1997 Edwards Lifesciences LLC Methods and devices for improving cardiac function in hearts
6418335, Jun 25 1996 Quantum Magnetics, Inc Ferromagnetic foreign body detection using magnetics
6427081, Feb 02 1999 SenoRx, Inc. Methods and chemical preparations for time-limited marking of biopsy sites
6445185, Sep 28 1992 Fonar Corporation Nuclear magnetic resonance apparatus and methods of use and facilities for incorporating the same
6549800, Apr 25 1996 Johns Hopkins University School of Medicine Methods for in vivo magnetic resonance imaging
6592608, Dec 07 2001 Merit Medical Systems, Inc Bioabsorbable sealant
6603308, Mar 10 2000 Sumitomo Electric Industries, Ltd. Superconducting magnetic sensor having a cryostet with a flux guide
6638913, Feb 29 1996 Bayer Schering Pharma Aktiengesellschaft Concentrated injection and infusion solution for intravenous administration
6662040, Jun 16 1997 GE HEALTHCARE AS Methods of photoacoustic imaging
6662041, Feb 02 1999 SenoRx, Inc. Imageable biopsy site marker
6699205, Jun 22 1998 DEVICOR MEDICAL PRODUCTS, INC Biopsy localization method and device
6725083, Feb 02 1999 Senorx, Inc Tissue site markers for in VIVO imaging
6766186, Jun 16 1999 C. R. Bard, Inc. Post biospy tissue marker and method of use
6815949, Jul 19 2001 Hitachi, Ltd. Apparatus for measuring a magnetic field
6835572, Oct 18 1999 SYDNEY, UNIVERSITY OF Magnetic resonance spectroscopy of breast biopsy to determine pathology, vascularization and nodal involvement
6850065, Jul 27 2001 General Electric Company MRI coil system for breast imaging
6862470, Feb 02 1999 Senorx, Inc Cavity-filling biopsy site markers
6889073, May 08 2000 LAMPMAN, DAVID A ; MASTANDREA, NICHOLAS J Breast biopsy and therapy system for magnetic resonance imagers
6920346, Apr 10 2001 Eurorad 2-6 (Societe Anonyme) Pre-operative device for localizing marked tissues and process using such a device
6949926, Jun 14 2002 HITACHI HIGH-TECH CORPORATION Biomagnetic measurement apparatus
6963769, Apr 21 1999 HEALTH AND HUMAN SERVICES, GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE, DEPARTMENT OF, THE Method for enhancing contrast produced by MRI
6996433, Feb 02 1999 SenoRx, Inc. Imageable biopsy site marker
7009398, Mar 20 2003 SIEMENS HEALTHINEERS AG Portable magnetic resonance surface coil unit with an access opening for manual gripping
7044957, Sep 16 1994 DEVICOR MEDICAL PRODUCTS, INC Devices for defining and marking tissue
7084631, Nov 19 2003 General Electric Company Magnetic resonance imaging array coil system and method for breast imaging
7116094, Jul 28 2004 International Business Machines Corporation Apparatus and method for transmission and remote sensing of signals from integrated circuit devices
7229417, Sep 16 1994 DEVICOR MEDICAL PRODUCTS, INC Methods for marking a biopsy site
7283868, Apr 07 2000 Johns Hopkins University, The Apparatus for sensing human prostate tumor
7329414, May 03 2002 Med-Genesis, LLC Biodegradable polymer for marking tissue and sealing tracts
7335511, Oct 18 1999 SYDNEY, UNIVERSITY OF Magnetic resonance spectroscopy to classify tissue
7386338, Apr 30 2004 General Electric Company Bilateral imaging apparatus
7412275, Dec 13 2002 E O OSPEDALI GALLIERA Susceptometer for non-invasive iron level measurement in a body
7416533, Aug 13 2003 SciMed Life Systems, Inc. Marking biopsy sites
7479784, Oct 12 2005 New York University Arrangements, systems and methods for facilitating and collecting information associated with fluxes of magnetic fields provided at various angles from one another
7525308, Jul 16 2004 Okayama University Magnetic detecting device and material identifying device
7535363, Sep 14 2001 Varian Medical Systems, Inc Miniature resonating marker assembly
7570056, Aug 10 2005 Toshiba Medical Systems Corporation Magnetic resonance imaging apparatus
7625397, Sep 16 1994 DEVICOR MEDICAL PRODUCTS, INC Methods for defining and marking tissue
7668582, Dec 24 1998 DEVICOR MEDICAL PRODUCTS, INC Biopsy site marker
7676256, Aug 14 2001 ESAOTE S P A Imaging apparatus
7680524, Oct 23 2001 Olympus Corporation Magnetic fluid detection method and magnetic fluid detection apparatus
7689267, Dec 28 1995 Method and apparatus for magnetic resonance imaging of arteries using a magnetic resonance contrast agent
7701209, Oct 05 2001 Fonar Corporation Coils for horizontal field magnetic resonance imaging
7702378, Nov 17 2005 BREAST-MED, INC Tissue marker for multimodality radiographic imaging
7711407, May 21 2004 DEVICOR MEDICAL PRODUCTS, INC MRI biopsy device localization fixture
7744852, Feb 09 2007 Encapsule Medical, LLC Methods and systems for marking post biopsy cavity sites
7783336, Jun 06 2003 DEVICOR MEDICAL PRODUCTS, INC Subcutaneous biopsy cavity marker device
7792569, Feb 02 1999 Senorx, Inc Cavity-filling biopsy site markers
7877133, May 23 2003 Senorx, Inc Marker or filler forming fluid
7972619, May 03 2002 Biopsy Sciences, LLC Biodegradable polymer for marking tissue and sealing tracts
8050742, Jul 30 2008 DEVICOR MEDICAL PRODUCTS, INC Biopsy device
8060183, Oct 13 2004 Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated Site marker visible under multiple modalities
8062215, Apr 13 2007 Ethicon Endo-Surgery, Inc Fluorescent nanoparticle scope
8064987, Oct 23 2006 C R BARD, INC Breast marker
8118754, Nov 15 2007 IMAGION BIOSYSTEMS, INC Magnetic needle biopsy
8137320, May 01 2007 Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated Securement for a surgical site marker and deployment device for same
8174259, Apr 29 2005 UNIVERSITY OF HOUSTON Apparatus and method for determining magnetic properties of materials
8219182, Feb 02 1999 Senorx, Inc Cavity-filling biopsy site markers
8277391, Sep 16 1994 DEVICOR MEDICAL PRODUCTS, INC Methods and devices for defining and marking tissue
8280486, Oct 13 2004 Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated Site marker visable under multiple modalities
20010011155,
20010012915,
20010049481,
20020019595,
20020035324,
20020161298,
20030016010,
20030078493,
20030141868,
20030214313,
20030216632,
20040109823,
20040162477,
20040236213,
20040249261,
20050033157,
20050059881,
20050148863,
20060074295,
20060173283,
20060258933,
20060270930,
20060293581,
20070093726,
20080074109,
20080097199,
20080146914,
20080161848,
20080214930,
20080228164,
20080275333,
20080294036,
20090024022,
20090082662,
20090118611,
20090164161,
20090201016,
20100030149,
20100099978,
20100125191,
20100305430,
20110021888,
20110133730,
20110137154,
20120229130,
DE102007009016,
DE29724862,
EP126580,
EP595227,
EP663599,
EP966924,
EP1062911,
EP1249207,
EP1284123,
EP1491147,
EP2267471,
EP2339343,
FR2689638,
FR2770779,
GB2109112,
GB2425610,
JP10038854,
JP2003149212,
JP2005168678,
JP2006030004,
JP2078983,
JP2281170,
JP5251774,
JP6324021,
JP8015229,
JP8248004,
JP8338864,
JP9027057,
WO38579,
WO239917,
WO2005011512,
WO2006009048,
WO2006022786,
WO2006056739,
WO2006117530,
WO2007034196,
WO2007053533,
WO2011033306,
WO2011067576,
WO2014013235,
WO9504287,
WO9807052,
///
Executed onAssignorAssigneeConveyanceFrameReelDoc
Dec 03 2010HATTERSLEY, SIMON RICHARDENDOMAGNETICS LTDASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0258050884 pdf
Dec 06 2010ENDOMAGNETICS LTD.(assignment on the face of the patent)
Jan 06 2011PANKHURST, QUENTIN ANDREWENDOMAGNETICS LTDASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0258050884 pdf
Date Maintenance Fee Events
Feb 17 2020M2551: Payment of Maintenance Fee, 4th Yr, Small Entity.
Feb 17 2020M2551: Payment of Maintenance Fee, 4th Yr, Small Entity.
Feb 07 2024M2552: Payment of Maintenance Fee, 8th Yr, Small Entity.
Feb 07 2024M2552: Payment of Maintenance Fee, 8th Yr, Small Entity.
Aug 05 2024BIG: Entity status set to Undiscounted (note the period is included in the code).


Date Maintenance Schedule
Aug 30 20194 years fee payment window open
Mar 01 20206 months grace period start (w surcharge)
Aug 30 2020patent expiry (for year 4)
Aug 30 20222 years to revive unintentionally abandoned end. (for year 4)
Aug 30 20238 years fee payment window open
Mar 01 20246 months grace period start (w surcharge)
Aug 30 2024patent expiry (for year 8)
Aug 30 20262 years to revive unintentionally abandoned end. (for year 8)
Aug 30 202712 years fee payment window open
Mar 01 20286 months grace period start (w surcharge)
Aug 30 2028patent expiry (for year 12)
Aug 30 20302 years to revive unintentionally abandoned end. (for year 12)